Kallioniemi O P, Joensuu H, Klemi P, Koivula T
Department of Clinical Chemistry, Tampere University Central Hospital, Finland.
Breast Cancer Res Treat. 1990 Nov;17(1):59-61. doi: 10.1007/BF01812686.
Consecutive sections from 33 paraffin-embedded human breast carcinomas without intratumor heterogeneity were sent for flow cytometric (FCM) DNA analysis in two experienced laboratories. FCM instruments, run conditions, and tumor disaggregation procedures were different in the two laboratories. In four cases (12%) the laboratories reported a different DNA ploidy and DNA index (DI). These variations were due to analytical reasons, differences in the detection rates of near-diploid and tetraploid DIs, not due to interpretation of data or the criteria used for aneuploidy. There was a significant correlation between S-phase fractions (SPF) obtained in the two laboratories (r = 0.90, p less than 0.0001) if only cases with concordant DI were included. Discordant DI usually led to very different SPF values.
从33例无肿瘤内异质性的石蜡包埋人乳腺癌中选取连续切片,送至两个经验丰富的实验室进行流式细胞术(FCM)DNA分析。两个实验室的FCM仪器、运行条件和肿瘤解离程序均不同。在4例(12%)病例中,两个实验室报告的DNA倍体和DNA指数(DI)不同。这些差异是由于分析原因、近二倍体和四倍体DI检测率的差异,而非数据解释或用于非整倍体的标准。如果仅纳入DI一致的病例,则两个实验室获得的S期分数(SPF)之间存在显著相关性(r = 0.90,p < 0.0001)。DI不一致通常导致非常不同的SPF值。